Clinicopathologic and prognostic roles of circular RNA plasmacytoma variant translocation 1 in various cancers

References

• Li Z, Huang C, Bao C, et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015 2015-03-01;22(3):256–264.
   PubMed Web of Science ®Google Scholar
• Sanger HL, Klotz G, Riesner D, et al. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci U S A. 1976 1976-11-01;73(11):3852–3856.
   PubMed Web of Science ®Google Scholar
• Xuan L, Qu L, Zhou H, et al. Circular RNA: a novel biomarker for progressive laryngeal cancer. Am J Transl Res. 2016 2016-01-20;8(2):932–939.
   PubMed Web of Science ®Google Scholar
• Ebbesen KK, Hansen TB, Kjems J. Insights into circular RNA biology. RNA Biol. 2017 2017-08-03;14(8):1035–1045.
   PubMed Web of Science ®Google Scholar
• Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013 2013-02-01;19(2):141–157.
   PubMed Web of Science ®Google Scholar
• Noto JJ, Schmidt CA, Matera AG. Engineering and expressing circular RNAs via tRNA splicing. RNA Biol. 2017 2017-08-03;14(8):978–984.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang XO, Chen T, et al. Circular intronic long noncoding RNAs. Mol Cell. 2013 2013-09-26;51(6):792–806.
   PubMed Web of Science ®Google Scholar
• Conn SJ, Pillman KA, Toubia J, et al. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015 2015-03-12;160(6):1125–1134.
   PubMed Web of Science ®Google Scholar
• Lasda E, Parker R. Circular RNAs: diversity of form and function. RNA. 2014 2014-12-01;20(12):1829–1842.
   PubMed Web of Science ®Google Scholar
• Danan M, Schwartz S, Edelheit S, et al. Transcriptome-wide discovery of circular RNAs in Archaea. Nucleic Acids Res. 2012 2012-04-01;40(7):3131–3142.
   PubMed Web of Science ®Google Scholar
• Kulcheski FR, Christoff AP, Margis R. Circular RNAs are miRNA sponges and can be used as a new class of biomarker. J Biotechnol. 2016 2016-11-20;238:42–51.
   PubMed Web of Science ®Google Scholar
• Misir S, Hepokur C, Aliyazicioglu Y, et al. Circular RNAs serve as miRNA sponges in breast cancer. Breast Cancer Tokyo. 2020 2020-11-01;27(6):1048–1057.
   PubMed Web of Science ®Google Scholar
• Panda AC. Circular RNAs act as miRNA sponges. Adv Exp Med Biol. 2018 2018-01-20;1087:67–79.
   PubMed Web of Science ®Google Scholar
• Li H, Jin X, Liu B, et al. CircRNA CBL.11 suppresses cell proliferation by sponging miR-6778-5p in colorectal cancer. BMC Cancer. 2019 2019-08-22;19(1):826.
   PubMed Web of Science ®Google Scholar
• Lu Q, Liu T, Feng H, et al. Circular RNA circSLC8A1 acts as a sponge of miR-130b/miR-494 in suppressing bladder cancer progression via regulating PTEN. Mol Cancer. 2019 2019-06-22;18(1):111.
   PubMed Web of Science ®Google Scholar
• Chen F, Feng Z, Zhu J, et al. Emerging roles of circRNA_NEK6 targeting miR-370-3p in the proliferation and invasion of thyroid cancer via Wnt signaling pathway. Cancer Biol Ther. 2018 2018-01-20;19(12):1139–1152.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang S, Wang H, et al. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway. Mol Cancer. 2019 2019-02-04;18(1):20.
   PubMed Web of Science ®Google Scholar
• Li F, Huang Q, Gong Z, et al. Diagnostic and prognostic roles of circ-SHPRH for solid cancers: a meta-analysis. Onco Targets Ther. 2019 2019-01-20;12:4351–4357.
   PubMed Web of Science ®Google Scholar
• Tian G, Li G, Guan L, et al. Prognostic value of circular RNA ciRS-7 in various cancers: a PRISMA-compliant meta-analysis. Biomed Res Int. 2020 2020-01-20;2020:1487609.
   PubMed Web of Science ®Google Scholar
• Wenzhe G, Jiahao X, Cheng P, et al. Circular RNA HIPK3 is a prognostic and clinicopathological predictor in malignant tumor patients. J Cancer. 2020 2020-01-20;11(14):4230–4239.
   PubMed Web of Science ®Google Scholar
• Borran S, Ahmadi G, Rezaei S, et al. Circular RNAs: new players in thyroid cancer. Pathol Res Pract. 2020 2020-10-01;216(10):153217.
   PubMed Web of Science ®Google Scholar
• Nahand JS, Jamshidi S, Hamblin MR, et al. Circular RNAs: new epigenetic signatures in viral infections. Front Microbiol. 2020 2020-01-20;11:1853.
   PubMed Web of Science ®Google Scholar
• Abbaszadeh-Goudarzi K, Radbakhsh S, Pourhanifeh MH, et al. Circular RNA and diabetes: epigenetic regulator with diagnostic role. Curr Mol Med. 2020 2020-01-20;20(7):516–526.
   PubMed Web of Science ®Google Scholar
• Shabaninejad Z, Vafadar A, Movahedpour A, et al. Circular RNAs in cancer: new insights into functions and implications in ovarian cancer. J Ovarian Res. 2019 2019-09-03;12(1):84.
   PubMed Web of Science ®Google Scholar
• Panda AC, Grammatikakis I, Kim KM, et al. Identification of senescence-associated circular RNAs (SAC-RNAs) reveals senescence suppressor CircPVT1. Nucleic Acids Res. 2017 2017-04-20;45(7):4021–4035.
   PubMed Web of Science ®Google Scholar
• Yan M, Gao H, Lv Z, et al. Circular RNA PVT1 promotes metastasis via regulating of miR-526b/FOXC2 signals in OS cells. J Cell Mol Med. 2020 2020-05-01;24(10):5593–5604.
   PubMed Web of Science ®Google Scholar
• Chen J, Li Y, Zheng Q, et al. Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer. Cancer Lett. 2017 2017-03-01;388:208–219.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for 410 reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009 Jul 21;339:b2700. DOI: https://doi.org/10.1136/bmj.b2700
   Google Scholar
• George W, Beverley JS, Dianne O, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000.
   Google Scholar
• Xu L, Zhang Y, Tang J, et al. The prognostic value and regulatory mechanisms of microRNA-145 in various tumors: a systematic review and meta-analysis of 50 studies. Cancer Epidemiol Biomarkers Prev. 2019 2019-05-01;28(5):867–881.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003 2003-09-06;327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Mantel N, HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 1959-04-01;22(4):719–748.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986 1986-09-01;7(3):177–188.
   PubMedGoogle Scholar
• Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997 1997-09-13;315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Ren X, He J, Qi L, et al. Prognostic and clinicopathologic significance of long non-coding RNA opa-interacting protein 5-antisense RNA 1 in multiple human cancers. Artif Cells Nanomed Biotechnol. 2020 2020-12-01;48(1):353–361.
   PubMed Web of Science ®Google Scholar
• Yao W, Guo P, Mu Q, et al. Exosome-derived Circ-PVT1 contributes to cisplatin resistance by regulating autophagy, invasion, and apoptosis via miR-30a-5p/YAP1 axis in gastric cancer cells. Cancer Biother Radiopharm. 2020;36(4):347–359.
   Web of Science ®Google Scholar
• Zheng F, Xu R. CircPVT1 contributes to chemotherapy resistance of lung adenocarcinoma through miR-145-5p/ABCC1 axis. Biomed Pharmacother. 2020 Apr 01;124:109828.
   PubMed Web of Science ®Google Scholar
• Bian Q. Circular RNA PVT1 promotes the invasion and epithelial-mesenchymal transition of breast cancer cells through serving as a competing endogenous RNA for miR-204-5p. Onco Targets Ther. 2019 Jan 20;12:11817–11826.
   PubMed Web of Science ®Google Scholar
• Qin S, Zhao Y, Lim G, et al. Circular RNA PVT1 acts as a competing endogenous RNA for miR-497 in promoting non-small cell lung cancer progression. BIOMED Pharmacother. 2019 Mar 01;111:244–250.
   PubMed Web of Science ®Google Scholar
• Verduci L, Ferraiuolo M, Sacconi A, et al. The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53/YAP/TEAD transcription-competent complex. Genome Biol. 2017 Dec 20;18(1):237.
   PubMed Web of Science ®Google Scholar
• Wang Z, Su M, Xiang B, et al. Circular RNA PVT1 promotes metastasis via miR-145 sponging in CRC. Biochem Biophys Res Commun. 2019 May 14;512(4):716–722.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Liu Y, Xiao B, et al. The circular RNA PVT1/miR-203/HOXD3 pathway promotes the progression of human hepatocellular carcinoma. Biol Open. 2019 Sep 24;8(9):bio043687.
   Web of Science ®Google Scholar
• Kun-Peng Z, Xiao-Long M, Chun-Lin Z. Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1. Int J Biol Sci. 2018 Jan 20;14(3):321–330.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019 Jan 01;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Karanikas M, Esempidis A, Chasan ZT, et al. Pancreatic cancer from molecular pathways to treatment opinion. J Cancer. 2016 Jan 20;7(10):1328–1339.
   PubMed Web of Science ®Google Scholar
• Jin M, Shi C, Yang C, et al. Upregulated circRNA ARHGAP10 predicts an unfavorable prognosis in NSCLC through regulation of the miR-150-5p/GLUT-1 axis. Mol Ther Nucleic Acids. 2019 Dec 06;18:219–231.
   PubMedGoogle Scholar
• Ren S, Liu J, Feng Y, et al. Knockdown of circDENND4C inhibits glycolysis, migration and invasion by up-regulating miR-200b/c in breast cancer under hypoxia. J Exp Clin Cancer Res. 2019 Sep 05;38(1):388.
   PubMed Web of Science ®Google Scholar
• Chen Y, Yang F, Fang E, et al. Circular RNA circAGO2 drives cancer progression through facilitating HuR-repressed functions of AGO2-miRNA complexes. Cell Death Differ. 2019 Jul 01;26(7):1346–1364.
   PubMed Web of Science ®Google Scholar
• Adhikary J, Chakraborty S, Dalal S, et al. Circular PVT1: an oncogenic non-coding RNA with emerging clinical importance. J Clin Pathol. 2019 Aug 01;72(8):513–519.
   PubMed Web of Science ®Google Scholar